|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-12-5
|
|
pubmed:abstractText |
Heparin addition to infusion fluids is used to prolong catheter patency in newborns. Heparin may also induce adverse effects such as bleeding complications and immune-mediated heparin-induced thrombocytopenia (HIT). One objective was peripheral venous catheter patency with heparinization of continuous infusions (0.5 IU/mL). Secondary objectives were incidences of bleeding, clinically manifest HIT, HIT antibodies, and catheter-related complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0022-3476
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
143
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
741-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14657819-Antibodies,
pubmed-meshheading:14657819-Anticoagulants,
pubmed-meshheading:14657819-Catheterization, Peripheral,
pubmed-meshheading:14657819-Catheters, Indwelling,
pubmed-meshheading:14657819-Coagulants,
pubmed-meshheading:14657819-Double-Blind Method,
pubmed-meshheading:14657819-Equipment Failure,
pubmed-meshheading:14657819-Female,
pubmed-meshheading:14657819-Hemorrhage,
pubmed-meshheading:14657819-Heparin,
pubmed-meshheading:14657819-Humans,
pubmed-meshheading:14657819-Infant, Newborn,
pubmed-meshheading:14657819-Infusions, Intravenous,
pubmed-meshheading:14657819-Male,
pubmed-meshheading:14657819-Platelet Factor 4,
pubmed-meshheading:14657819-Risk Assessment,
pubmed-meshheading:14657819-Thrombocytopenia
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Benefit and risk of heparin for maintaining peripheral venous catheters in neonates: a placebo-controlled trial.
|
|
pubmed:affiliation |
Department of Pediatrics, the Institute of Immunology and Transfusion Medicine, and the University Pharmacy, Ernst-Moritz-Arndt University, Greifswald, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
